Summary of Significant Accounting Policies - Segments (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)
Medical Indication Information
Number of reportable segments | segment			1
Total net sales	$ 80,894	$ 86,508	$ 155,973	$ 188,033
Analgesic
Medical Indication Information
Total net sales	2,592	3,919	6,016	9,233
Anti-Psychosis
Medical Indication Information
Total net sales	2,575	2,095	5,195	5,810
Cardiovascular
Medical Indication Information
Total net sales	13,089	9,753	23,971	23,853
Central Nervous System
Medical Indication Information
Total net sales	21,782	22,340	42,576	45,125
Endocrinology
Medical Indication Information
Total net sales	5,831	8,297	13,143	16,142
Gastrointestinal
Medical Indication Information
Total net sales	8,716	14,023	16,658	29,263
Infectious Disease
Medical Indication Information
Total net sales	4,989	6,520	10,058	19,035
Migraine
Medical Indication Information
Total net sales	3,574	4,446	6,898	9,131
Respiratory/Allergy/Cough/Cold
Medical Indication Information
Total net sales	1,468	1,868	2,670	4,982
Other
Medical Indication Information
Total net sales	10,955	10,275	19,714	20,627
Contract manufacturing revenue
Medical Indication Information
Total net sales	$ 5,323	$ 2,972	$ 9,074	$ 4,832